In the past week, COGT stock has gone up by 16.39%, with a monthly decline of -0.36% and a quarterly plunge of -19.86%. The volatility ratio for the week is 6.05%, and the volatility levels for the last 30 days are 5.96% for Cogent Biosciences Inc The simple moving average for the last 20 days is 11.32% for COGT stock, with a simple moving average of -32.56% for the last 200 days.
Is It Worth Investing in Cogent Biosciences Inc (NASDAQ: COGT) Right Now?
The stock has a 36-month beta value of 1.83. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 4 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for COGT is 94.03M, and at present, short sellers hold a 16.56% of that float. On June 03, 2025, the average trading volume of COGT was 1.32M shares.
COGT) stock’s latest price update
Cogent Biosciences Inc (NASDAQ: COGT)’s stock price has plunge by 3.13relation to previous closing price of 5.44. Nevertheless, the company has seen a 16.39% surge in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-29 that WALTHAM, Mass. and BOULDER, Colo.
Analysts’ Opinion of COGT
Many brokerage firms have already submitted their reports for COGT stocks, with Scotiabank repeating the rating for COGT by listing it as a “Sector Outperform.” The predicted price for COGT in the upcoming period, according to Scotiabank is $17 based on the research report published on March 07, 2025 of the current year 2025.
Robert W. Baird gave a rating of “Neutral” to COGT, setting the target price at $8 in the report published on February 26th of the previous year.
COGT Trading at 8.78% from the 50-Day Moving Average
After a stumble in the market that brought COGT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.51% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COGT starting from Pinnow Cole, who purchase 43,750 shares at the price of $7.60 back on Jan 14 ’25. After this action, Pinnow Cole now owns 45,848 shares of Cogent Biosciences Inc, valued at $332,412 using the latest closing price.
Stock Fundamentals for COGT
The total capital return value is set at -1.23. Equity return is now at value -84.04, with -70.93 for asset returns.
Based on Cogent Biosciences Inc (COGT), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -12.98.
Currently, EBITDA for the company is -275.94 million with net debt to EBITDA at 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.13.
Conclusion
To sum up, Cogent Biosciences Inc (COGT) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
